Zusammenfassung
In einer randomisierten Doppelblindstudie wurde der Effekt von Aprotinin (2000000 KIE als Bolus+500000 KIE/h bis zum Ende der Operation, Verumgruppe n=9; Plazebogruppe n=9) auf Gerinnungsparameter und Transfusionsbedarf bei orthotoper Lebertransplantation untersucht. Alle Patienten wurden mit Hilfe eines fahrbaren Gerinnungslabors intraoperativ optimal überwacht. Im Gegensatz zu anderen Arbeitsgruppen fand sich unter diesen Bedingungen für den Transfusionsbedarf kein signifikanter Unterschied zwischen Verum- und Plazebogruppe. Dagegen beobachteten wir einen günstigen Effekt des Proteinaseninhibitors auf verschiedene Gerinnungsparameter, besonders in der Reperfusionsphase. Offensichtlich wird die Kontaktaktivierung des intrinsischen Gerinnungssystems, die durch geschädigte Gefäße des transplantierten Organs eingeleitet wird, durch Aprotinin gehemmt.
Abstract
The effect of aprotinin (2000000 IU as a bolus +500000 JU/h until the end of the operation) on transfusion requirements and coagulation parameters in orthotopic liver transplantation (study group: n=9; placebo group: n=9) was investigated in a randomised, double-blind study. Coagulation parameters were monitored intraoperatively using a mobile laboratory. In contrast to the published results, no effect on transfusion requirements could be demonstrated. However, aprotinin showed a positive effect on some coagulation parameters in the reperfusion phase. The mechanism appeared to be inhibition of the contact activation of the intrinsic system with less thrombin generation in the study group.
Literatur
Azad SC, Kratzer MAA, Groh J, Welte M, Haller M, Pratschke E (1993) Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation. Sem Thromb Hemost 19:233–237
Blake JC, Sprengers D, Grech P, McCormick PA, McIntyre N, Burroughs AK (1990) Bleeding time in patients with hepatic cirrhosis. Br Med J 301:12–15
Dietrich W, Barankay A, Dilthey G, Henze R, Niekau E, Sebening F, Richter JA (1989) Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application. Thor Cardiovasc Surg 37:92–98
Fraedrich G, Weber C, Bernard C, Hettwer A, Schlosser V (1989) Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin. Thor Cardiovasc Surg 37:89–91
Gaddum JH (1945) Lognormal distributions. Nature 156:463–466
Groh J, Welte M, Azad SC, Anthuber M, Haller M, Kratzer MAA (1993) Does aprotinin really reduce blood loss in orthotopic liver transplantation? Sem Thromb Hemost 19:306–308
Groh J, Welte M, Azad SC, Forst H, Pratschke E, Kratzer MAA (1993) Does aprotinin affect blood loss in liver transplantation? Lancet 340:173
Grosse H, Lobbes W, Frambach M, von Broen O, Ringe B, Barthels M (1991) The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss. Thromb Res 63:287–297
Kratzer MAA, Born GVR (1985) Simulation of primary haemostasis in vitro. Haemostasis 15:357–362
Kratzer MAA, Dieterich J, Deneke H, Knedel M (1991) Hemostatic variables and blood loss during orthotopic human liver transplantation. Transplant Proc 23:1906–1911
Lie TS, Seger R, Hong GS, Preisinger H, Ogawa K (1989) Protective effect of aprotinin on ischemic hepatocellular damage. Transplantation 48:396
Mallet SV, Cox DJA, Burroughs AK, Rolles K (1990) Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation. Lancet 336:886–887
Marcel RJ, Stegall WC, Suit CT, Arnold JC, Vera RL, Ramsay MA, O’Donnell MB, Swygert TH, Hein HA, Whitten CW (1996) Continuous small dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg 82:1122–1125
Monedero P, Paramo JA, Carrascosa F, Herrero JI, Hildago F, Iribarren MJ, Garcia Pedrajas F (1995) Reduction of the need for blood derivatives in liver transplantation using aprotinin. Rev Esp Anestesiol Reanim 42:82–86
Mor E, Jennings L, Gonwa TA, Holman MJ, Gibbs J, Solomon H, Goldstein R, Husberg BS, Watemberg I, Klintmalm G (1993) The impact of operative bleeding on outcome in transplantation of liver. Surg Gynecol Obstet 176:219–227
Neuhaus P, Bechstein WO, Lefebre B, Blumhardt G, Slama K (1989) Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 924–925
Patrassi GM, Viero M, Sartori MT, De Silvestro G, Rossaro L, Burra P, Nolli ML (1994) Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion 34:507–511
Royston D, Bidstrup BP, Taylor KM, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 11:1289
Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC (1995) Changes in the contact system during orthotopic liver transplantation with and without aprotinin. Transplantation 59:366–370
Welte M, Groh J, Azad SC, Anthuber M, Haller M, Kratzer MAA (1993) Effect of aprotinin on coagulation parameters in liver transplantation. Sem Thromb Hemost 19:297–299
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kratzer, M.A.A., Azad, S.C., Groh, J. et al. Die Wirkung von Aprotinin. Anaesthesist 46, 294–302 (1997). https://doi.org/10.1007/s001010050404
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001010050404